SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001179110-06-019131
Filing Date
2006-09-28
Accepted
2006-09-28 19:51:18
Documents
1
Period of Report
2006-06-16

Document Format Files

Seq Description Document Type Size
1 FORM 4/A - edgar.html 4/A  
1 FORM 4/A - edgar.xml 4/A 4473
  Complete submission text file 0001179110-06-019131.txt   6439
Mailing Address 300 ELLIOTT AVENUE WEST SUITE 500 SEATTLE WA 98119-4114
Business Address 300 ELLIOTT AVENUE WEST SUITE 500 SEATTLE WA 98119-4114 2062817001
PONIARD PHARMACEUTICALS, INC. (Issuer) CIK: 0000755806 (see all company filings)

IRS No.: 911261311 | State of Incorp.: WA | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 300 ELLIOTT AVENUE WEST SUITE 500 SEATTLE WA 98119-4114
Business Address 206-281-7001
McMahon Gerald PhD (Reporting) CIK: 0001290747 (see all company filings)

Type: 4/A | Act: 34 | File No.: 000-16614 | Film No.: 061115247